Status:
COMPLETED
Feasibility of MRI Workflow Alone in External Radiotherapy for the Treatment of Brain and Prostate Tumors
Lead Sponsor:
Institut Cancerologie de l'Ouest
Conditions:
Prostate Cancer
Brain Cancer
Eligibility:
All Genders
18+ years
Brief Summary
In radiotherapy, Magnetic Resonance Imaging (MRI) is used as a complement to the CT scanner because it provides better tissue contrast and therefore more precise delineations without the need for addi...
Detailed Description
This is a prospective single-center dosimetry study that exhaustively included brain tumor and prostate cancer patients treated at the ICO Site d'Angers by external radiotherapy and prior to which the...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old
- Male or Female with a (primary) brain tumour or Male with cancer and localized (non-metastatic) prostate cancer
- Patient having benefited from a planning MRI scan in treatment position performed according to the new acquisition modalities (allowing the generation of CT-synthetics by automatic assignment of densities) performed since January 2020 and a planning scanner in treatment position prior to external radiotherapy.
- Good general condition (SP \< 3)
Exclusion
- Excluded forms of the disease,
- MRI-specific contraindications (claustrophobia, foreign bodies)
- Obesity preventing the placement of equipment (contention/antennae)
- Poor general condition (SP \> or = 2) preventing the patient from standing on the table -
Key Trial Info
Start Date :
July 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 15 2021
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT04704804
Start Date
July 24 2020
End Date
July 15 2021
Last Update
March 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de Cancerologie de L'Ouest
Angers, France, 49055